Kanabo Group (LON:KNB) Stock Price Down 4.9% – What’s Next?

Kanabo Group Plc (LON:KNB)’s stock price was down 4.9% during mid-day trading on Monday . The stock traded as low as GBX 0.92 ($0.01) and last traded at GBX 0.95 ($0.01). Approximately 540,018 shares traded hands during mid-day trading, an increase of 20% from the average daily volume of 451,386 shares. The stock had previously closed at GBX 1 ($0.01).

Kanabo Group Stock Down 8.0 %

The company has a quick ratio of 24.36, a current ratio of 2.78 and a debt-to-equity ratio of 3.49. The stock has a 50-day simple moving average of GBX 1.18 and a two-hundred day simple moving average of GBX 1.42. The firm has a market cap of £5.82 million, a PE ratio of -110.00 and a beta of 3.04.

Insider Activity at Kanabo Group

In other Kanabo Group news, insider Ian Mattioli purchased 150,000 shares of Kanabo Group stock in a transaction on Tuesday, August 27th. The shares were acquired at an average cost of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,958.74). 37.01% of the stock is currently owned by insiders.

Kanabo Group Company Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.